SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-045273
Filing Date
2018-07-16
Accepted
2018-07-16 16:17:52
Documents
33
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-16227_110q.htm 10-Q 295363
2 EX-31.1 a18-16227_1ex31d1.htm EX-31.1 10821
3 EX-31.2 a18-16227_1ex31d2.htm EX-31.2 10793
4 EX-32.1 a18-16227_1ex32d1.htm EX-32.1 6281
5 EX-32.2 a18-16227_1ex32d2.htm EX-32.2 6256
  Complete submission text file 0001104659-18-045273.txt   1166262

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20180531.xml EX-101.INS 123446
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20180531.xsd EX-101.SCH 14787
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20180531_cal.xml EX-101.CAL 15646
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20180531_lab.xml EX-101.LAB 138634
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20180531_pre.xml EX-101.PRE 85712
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20180531_def.xml EX-101.DEF 32376
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 18954625
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences